The pharmaceutical companies Merck and Schering-Plough, which co-market the cholesterol drug Vytorin, "have gone into damage-control mode, taking out newspaper ads." The PR campaign follows the companies' reluctant publication of a study showing that neither of the drugs present in Vytorin "reduced the buildup of fatty plaque in arteries." The study "

Following a damaging Associated Press report that Blackwater Worldwide "repaired and repainted its trucks immediately after a deadly September shooting in Baghdad, making it difficult to determine whether enemy gunfire provoked the attac

The Center for Public Integrity "has released the first analysis of its kind, Iraq – The War Card: Orchestrated Deception on the Path to War ...